Vetoquinol SA (EPA:VETO)
France · Delayed Price · Currency is EUR 70.50
-0.50 (-0.70%)
Aug 21, 2026, 5:35 PM CET
Vetoquinol Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 525.69 | 539.2 | 529.27 | 539.78 | 521.27 | |
Revenue Growth | -2.51% | 1.88% | -1.95% | 3.55% | 21.94% |
Cost of Revenue | 217.73 | 240 | 237.89 | 241.74 | 228.63 |
Gross Profit | 307.96 | 299.2 | 291.38 | 298.04 | 292.65 |
Selling, General & Admin | 192.23 | 192.9 | 182.56 | 178.21 | 176.09 |
Amortization of Goodwill & Intangibles | 12.71 | 12.91 | 13.39 | 14.06 | 14.07 |
Other Operating Expenses | 3.66 | -2.25 | -0.81 | 3.85 | 1.94 |
Operating Expenses | 228.13 | 222.65 | 213.37 | 213.61 | 210.9 |
Operating Income | 79.83 | 76.55 | 78.01 | 84.43 | 81.75 |
Interest Expense | -1.26 | -1.07 | -0.92 | -1 | -0.62 |
Interest & Investment Income | 5.31 | 5.95 | 3.27 | 0.81 | 0.37 |
Earnings From Equity Investments | - | - | - | - | 0.13 |
Currency Exchange Gain (Loss) | -1.75 | -1.03 | 0.61 | -0.7 | 0.88 |
Other Non Operating Income (Expenses) | -0.15 | 0 | -0.16 | -0.33 | -0.37 |
EBT Excluding Unusual Items | 81.99 | 80.4 | 80.81 | 83.22 | 82.13 |
Merger & Restructuring Charges | - | - | - | - | -0.49 |
Impairment of Goodwill | -0.5 | - | - | -9.48 | - |
Gain (Loss) on Sale of Assets | 0.11 | 1.18 | 0.09 | 0.3 | 0.99 |
Asset Writedown | - | -0 | -3.57 | -1.01 | - |
Legal Settlements | -1.32 | -0.56 | -0.42 | -0.22 | - |
Other Unusual Items | - | - | - | -0.08 | 4.01 |
Pretax Income | 80.28 | 81.01 | 76.91 | 72.74 | 86.64 |
Income Tax Expense | 22.94 | 22.33 | 21.34 | 24.74 | 23.78 |
Earnings From Continuing Operations | 57.34 | 58.68 | 55.57 | 48 | 62.87 |
Minority Interest in Earnings | 0.02 | 0.01 | -0.01 | -0 | -0.01 |
Net Income | 57.36 | 58.69 | 55.56 | 48 | 62.86 |
Net Income to Common | 57.36 | 58.69 | 55.56 | 48 | 62.86 |
Net Income Growth | -2.26% | 5.63% | 15.76% | -23.65% | 227.04% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 |
Shares Change | -1.47% | -0.31% | 0.01% | 0.03% | -0.03% |
EPS (Basic) | 4.94 | 4.98 | 4.70 | 4.06 | 5.31 |
EPS (Diluted) | 4.94 | 4.98 | 4.70 | 4.06 | 5.31 |
EPS Growth | -0.80% | 5.95% | 15.75% | -23.67% | 227.00% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 55.05 | 71.28 | 74.5 | 45.88 | 75.9 |
Free Cash Flow Per Share | 4.74 | 6.04 | 6.30 | 3.88 | 6.42 |
Dividend Per Share | 0.930 | 0.890 | 0.850 | 0.800 | 0.800 |
Dividend Growth | 4.49% | 4.71% | 6.25% | 0% | 60.00% |
Gross Margin | 58.58% | 55.49% | 55.05% | 55.22% | 56.14% |
Operating Margin | 15.19% | 14.20% | 14.74% | 15.64% | 15.68% |
Profit Margin | 10.91% | 10.88% | 10.50% | 8.89% | 12.06% |
Free Cash Flow Margin | 10.47% | 13.22% | 14.07% | 8.50% | 14.56% |
EBITDA | 103.44 | 98.69 | 105.4 | 108.44 | 107.57 |
EBITDA Margin | 19.68% | 18.30% | 19.91% | 20.09% | 20.64% |
D&A For EBITDA | 23.61 | 22.14 | 27.39 | 24.02 | 25.82 |
EBIT | 79.83 | 76.55 | 78.01 | 84.43 | 81.75 |
EBIT Margin | 15.19% | 14.20% | 14.74% | 15.64% | 15.68% |
Effective Tax Rate | 28.57% | 27.57% | 27.75% | 34.02% | 27.44% |
Advertising Expenses | 22.58 | 24.22 | 23.12 | 23.57 | 26.85 |